ArticleOncoTargets and therapy2019

MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression.

Wei Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.